KRYS - Krystal Biotech GAAP EPS of $2.79 beats by $3.46 revenue of $8.6M beats by $2.31M
2023-11-06 07:07:09 ET
More on Krystal Biotech
- Krystal Biotech: FDA Approval Of Vyjuvek And Further Pipeline Enhancement
- Cantor starts Krystal Biotech at overweight, cites Vyjuvek launch
- Seeking Alpha’s Quant Rating on Krystal Biotech
- Historical earnings data for Krystal Biotech
For further details see:
Krystal Biotech GAAP EPS of $2.79 beats by $3.46, revenue of $8.6M beats by $2.31M